Cerebras IPO Surge Fuels Speculation Around SpaceX OpenAI but Raises Concerns for Smaller Players Nike NKE RiskReward Analysis Evaluating Current Market Positioning Century Therapeutics IPSC Q1 2026 Earnings Beat Revenue NA EPS 011 Canaan CAN Q4 2025 Earnings Miss by Significant Key Takeaways AIResistant Stocks Gain Traction New ETF Targets HALO Theme Meta Begins Mass Layoffs Amid AI Pivot Shares Edge Lower Lexeo Therapeutics LXEO Sees Mild Gains as Stock Holds Above Key Support Alnylam Pharmaceuticals ALNY Holds Gains Near Key Resistance as Support Levels Firm